|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
|LCTX||Lineage Cell Therapeutics||2.79||-0.01||-0.36%||454M|
You can purchase shares of Lineage Cell Therapeutics (AMEX: LCTX) through any online brokerage.
There are no as such competitors for Lineage Cell Therapeutics.
The latest price target for Lineage Cell Therapeutics (AMEX: LCTX) was reported by Cantor Fitzgerald on March 31, 2021. The analyst firm set a price target for 6.00 expecting LCTX to rise to within 12 months (a possible 114.29% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $2.8 last updated Today at 7:59:51 PM.
There are no upcoming dividends for Lineage Cell Therapeutics.
There is no upcoming split for Lineage Cell Therapeutics.
Lineage Cell Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the AMEX.